Evidence map›Paper›PMID 20080098›Full record

ReviewGastroenterology2010

History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Stuart Jon Spechler, Rebecca C Fitzgerald, Ganapathy A Prasad, Kenneth K Wang

Abstract readHistorical ArticleReview
In one paragraph

Review in Gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2.Esophagus : official journal of the Japan Esophageal Society · 2019
    Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. RISK OF PRENEOPLASTIC LESIONS IN MUCOSAL PROJECTIONS OF DIFFERENT SIZES OF THE COLUMNAR EPITHELIUM IN THE LOWER ESOPHAGUS.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2022
    Article
  10. Nitric oxide and inducible nitric oxide synthase levels in EE and NERD patients.Gastroenterology and hepatology from bed to bench · 2022
    Article
  11. Annals of translational medicine · 2021
    Review
  12. Alterations in the CaExploration of targeted anti-tumor therapy · 2021
    Article
  13. Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception.Cellular and molecular gastroenterology and hepatology · 2021
    Article
  14. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.Clinical and translational gastroenterology · 2020
    Article
  15. Review
  16. Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model.Esophagus : official journal of the Japan Esophageal Society · 2019
    Article
  17. Barretts's carcinogenesis.Pathology international · 2019
    Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Stuart Jon SpechlerVA North Texas Healthcare System and The University of Texas Southwestern Medical Center, Dallas, Texas, USA. sjspechler@aol.com
Rebecca C Fitzgerald
Ganapathy A Prasad
Kenneth K Wang

Funding

Biomarkers in Phototherapy of Barrett's EsophagusR01CA097048 · NCI · MAYO CLINIC ROCHESTER · PI WANG, KENNETH K · 2002 to 2010
$2.3M
Endoscopic Therapy of Early Cancer in Barretts EsophagusR01CA111603 · NCI · MAYO CLINIC ROCHESTER · PI WANG, KENNETH K · 2005 to 2009
$1.6M
Basic and Clinical Studies on the Role of Bile Acids in Barrett's EsophagusR01CA134571 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SOUZA, RHONDA F, SPECHLER, STUART JON · 2009 to 2013
$1.3M
Novel Method of Surveillance in Barrett's EsophagusR21CA122426 · NCI · MAYO CLINIC ROCHESTER · PI WANG, KENNETH K · 2007 to 2008
$298k
Medical Research Council MC_U105365007NCI NIH HHS R01CA097048NCI NIH HHS R01CA111603NCI NIH HHS R01 CA134571NCI NIH HHS R01-CA134571NCI NIH HHS R21CA122426
6 · The paper itself

Abstract

This report is an adjunct to the American Gastroenterological Association Institute's medical position statement and technical review on the management of Barrett's esophagus, which will be published in the near future. Those documents will consider a number of broad questions on the diagnosis, clinical features, and management of patients with Barrett's esophagus, and the reader is referred to the technical review for an in-depth discussion of those topics. In this report, we review historical, molecular, and endoscopic therapeutic aspects of Barrett's esophagus that are of interest to clinicians and researchers.

Indexed as

EsophagoscopyBarrett EsophagusCell Transformation, NeoplasticEsophageal NeoplasmsEsophagusHistory, 19th CenturyHistory, 20th CenturyHumansMetaplasiaPrecancerous ConditionsRisk FactorsTreatment Outcome

Identifiers

PMID20080098
PMCPMC2853870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.